Drawing for KYMADUR

USPTO serial 77624388

KYMADUR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
YOUNG, CARRIE SKYE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KYMADUR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David H. McDonald

David H. McDonald Abbott Laboratories100 Abbott Park RoadD377/AP6AAbbott Park, IL 60064-6008

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer, auto-immune diseases, cardiovascular disorders, obesity, neurological disorders, viral diseases and pain, excluding drug delivery systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 21, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 20, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 13, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 12, 2011EX2GSOU EXTENSION 2 GRANTED—
Jul 7, 2011EXT2SOU EXTENSION 2 FILED—
Jul 7, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 6, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 10, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2011EX1GSOU EXTENSION 1 GRANTED—
Feb 9, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 19, 2011EXT1SOU EXTENSION 1 FILED—
Jan 19, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 20, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 11, 2010ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Apr 9, 2010CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Apr 7, 2010APETASSIGNED TO PETITION STAFF—
Apr 2, 2010EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 19, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 27, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 22, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2009ALIEASSIGNED TO LIE—
Sep 9, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2009DOCKASSIGNED TO EXAMINER—
Dec 5, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance